FDA Drug Application (073098) for PEG-LYTE by SANDOZ

Back to FDA Applications sponsored by SANDOZ

Application Number073098
Product Number001
FormFOR SUSPENSION;ORAL
Dosage236GM/BOT;2.97GM/BOT;6.74GM/BOT;5.86GM/BOT;22.74GM/BOT
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePEG-LYTE
Active IngredientPOLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS

Active IngredientCount
List of drugs with Active Ingredient POLYETHYLENE GLYCOL 335028
List of drugs with Active Ingredient POTASSIUM CHLORIDE279
List of drugs with Active Ingredient SODIUM BICARBONATE53
List of drugs with Active Ingredient SODIUM CHLORIDE352
List of drugs with Active Ingredient SODIUM SULFATE ANHYDROUS12


Back to FDA Applications sponsored by SANDOZ